已收盘 11-07 16:00:00 美东时间
-0.990
-0.32%
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
10-31 10:25
Citigroup analyst Patrick Donnelly maintains Bio-Rad Laboratories (NYSE:BIO) with a Buy and raises the price target from $350 to $375.
10-31 02:23
Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.26 per share which beat the analyst consensus estimate of $1.93 by 16.92 percent. This is a 11.88 percent increase over earnings of $2.02 per share from
10-30 05:41
Full-Year 2025 Financial OutlookBio-Rad is maintaining its financial outlook for the full year 2025. The company continues to expect non-GAAP, currency-neutral revenue growth of approximately 0 to 1.0 percent and a
10-30 04:18
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Belite Bio Inc. (NASDAQ: BLTE), a clinical-stage drug development company focused on novel therapeutics for degenerative retinal diseases and metabolic conditions, announced that its executive management team will present at the Deutsche Bank ADR Virtual Investor Conference on November 4, 2025. The presentation will include a corporate overview, with a webcast available on the conference website at www.adr.db.com/dbvic and accessible for 90 days....
10-29 12:00
BIO-key International (NASDAQ: BKYI) shares surge 166% premarket after partnering with IT2Trust to expand GDPR-compliant IAM and biometric solutions across the Nordic region.
10-27 21:18
PPTA: 14% | Perpetua Resources shares are trading higher after the company entered agreements to raise $255 million in equity investments from Agnico Eagle Mines and JPMorgan Chase in a private placement. BKYI:
10-27 19:33
FORT WAYNE, Ind., Oct. 27, 2025 /PRNewswire/ -- Steel Dynamics, Inc. (NASDAQ/GS: STLD) today announced lower-embodied-carbon steel product offerings, BIOEDGE™ and EDGE™, to support customers...
10-27 19:00